Home > Insider Trading > Filing (0001415889-21-000330)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc. 201 Industrial Rd Suite 410 San Carlos CA 94070	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-01-13	1,118	$10.41	38,282	No	4	M	Direct
Common Stock	Acquisiton	2021-01-13	1,042	$10.73	39,324	No	4	M	Direct
Common Stock	Acquisiton	2021-01-13	1,526	$9.29	40,850	No	4	M	Direct
Common Stock	Acquisiton	2021-01-13	1,042	$13.01	41,892	No	4	M	Direct
Common Stock	Acquisiton	2021-01-13	1,042	$20.27	42,394	No	4	M	Direct
Common Stock	Acquisiton	2021-01-13	2,385	$25.46	45,319	No	4	M	Direct
Common Stock	Disposition	2021-01-13	8,155	$115.00	37,164	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	1,118	$0.00	1,118	$10.41
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	1,042	$0.00	1,042	$10.73
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	1,526	$0.00	1,526	$9.29
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	1,042	$0.00	1,042	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	1,042	$0.00	1,042	$20.27
Common Stock	Stock Option (right to buy)	Disposition	2021-01-13	2,385	$0.00	2,385	$25.46

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,719	2027-06-08	No	4	M	Direct
4,063	2027-07-13	No	4	M	Direct
47,161	2028-03-08	No	4	M	Direct
52,812	2029-01-10	No	4	M	Direct
59,062	2029-04-11	No	4	M	Direct
39,646	2030-03-26	No	4	M	Direct

Footnotes

The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.